Results 181 to 190 of about 490,601 (215)

[Importance of hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer].

Bulletin du cancer, 2010
Hyperthermic intraperitoneal chemotherapy (HIPEC) represents a new treatment strategy aimed to improve outcome of patients with advanced ovarian cancer. Based on theoretical and experimental basis, HIPEC should stand as an effective treatment for ovarian cancer.
Gwénaël, Ferron, Alejandra, Martinez, Eliane, Mery, Denis, Querleu, Fabienne, Thomas, Etienne, Chatelut, Laurence, Gladieff   +6 more
openaire   +1 more source

Anesthesia for Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC)

2021
Cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) is an acceptable therapeutic modality for peritoneal surface malignancies. Such surgeries are challenging to anesthesiologists due to many concerns in the perioperative period related to CRS and HIPEC phases specifically.
openaire   +1 more source

Skin necrosis following hyperthermic intraperitoneal chemotherapy (HIPEC) with mitomycin C

BMJ Case Reports
This article describes the case of a man in the early 50s diagnosed with left-sided colon cancer with peritoneal metastasis, who underwent neoadjuvant chemotherapy, followed by laparoscopic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC). One week postoperatively, he developed a painful, erythematous rash over the left flank,
Emerik Arseneault-Monette, Kadhim Taqi, Lloyd Mack, Antoine Bouchard-Fortier   +3 more
openaire   +2 more sources

The Emerging Role of Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Pancreatic Cancer

Journal of Surgical Oncology
ABSTRACTPeritoneal spread is a frequent cause of metastasis in both the synchronous and metachronous settings for patients with pancreatic cancer. Recent improvements in systemic chemotherapy for pancreatic cancer may now allow for the careful selection of patients with oligometastatic disease isolated to the peritoneum who may benefit from ...
Cornelius Thiels, Travis E. Grotz
openaire   +2 more sources

Infrared Thermography Monitoring in Closed Hyperthermic Intraperitoneal Chemotherapy (HIPEC)

2014
Introduction: Intraperitoneal hyperthermia is an essential part of the HIPEC procedure. The selective destruction of malignant cells by hyperthermia in the range of 41 to 43°C has been already demonstrated within adequate experimental and clinical studies. We report the worldwide first use of an[for full text, please go to the a.m. URL]
Jäger, T, Augschöll, C, Dinnewitzer, A, Öfner, D   +3 more
openaire   +1 more source

10289 Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Ovarian Cancer

Journal of Minimally Invasive Gynecology, 2023
S Puntambekar, S Inampudi, A Puntambekar, M Patil, M Chitale   +4 more
openaire   +1 more source

Emergencies After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)

2016
Since its first description by Spratt in 1980 (Cancer Res 40:253–255, 1980) and further refinement by Sugarbaker, cytoreductive surgery complemented by hyperthermic intraperitoneal chemotherapy (HIPEC) (Ann Surg 221:29–42, 1995) has gained popularity and has entered mainstream care for multiple peritoneal surface malignancies including pseudomyxoma ...
Sinziana Dumitra, Byrne Lee
openaire   +1 more source

The Contemporary Management of Peritoneal Metastasis: A Journey From the Cold Past of Treatment Futility to a Warm Present and a Bright Future

Ca-A Cancer Journal for Clinicians, 2023
Chunmeng Zhang, Prateek Sharma, Jason M Foster   +2 more
exaly  

Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for the Management of Primary Advanced and Recurrent Ovarian Cancer: A Systematic Review and Meta-Analysis of Randomized Trials

ESMO Open, 2022
Georgios Markozannes, Konstantinos K Tsilidis, D Mauri   +2 more
exaly  

Hyperthermic intraperitoneal chemotherapy (HIPEC) in gynecologic malignancies

Gynecologic Oncology, 2014
openaire   +1 more source